DACS
BIIB icon

Dymon Asia Capital (Singapore)’s Biogen BIIB Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,000
Closed -$2.75M – 249
2026
Q1 		$2.75M Buy
+15,000
New +$2.76M 0.28% 101

Other funds holding BIIB

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

Dymon Asia Capital (Singapore)'s BIIB Position: Q2 2026 in Review

Dymon Asia Capital (Singapore) sold out of Biogen (BIIB) in Q2 2026, closing a stake of 15,000 shares — an estimated $2.75M sold.

Dymon Asia Capital (Singapore) first reported a position in BIIB in Q1 2026 and held it in 1 quarter. The position peaked at $2.75M in Q1 2026. 405 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Dymon Asia Capital (Singapore) reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
  • Dymon Asia Capital (Singapore) sold 15,000 Biogen shares in Q2 2026, an estimated $2.75M.
  • Dymon Asia Capital (Singapore) first reported a position in Biogen in Q1 2026 and held it in 1 quarter.
  • Dymon Asia Capital (Singapore)'s Biogen position peaked at $2.75M in Q1 2026.
  • 405 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2026, filed 23 Jul 2026.